Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nischarin (Homo sapiens (Human)) | BDBM215802 (US9303019, 8) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 0.220 | -57.3 | n/a | n/a | n/a | n/a | n/a | 7.35 | 37 |
UNIVERSITE DE STRASBOURG US Patent | Assay Description Binding assays were performed at 37° C. using [125I]LNP 911 as radioligand following the general procedure described but adapted to washed whole ... | US Patent US9303019 (2016) BindingDB Entry DOI: 10.7270/Q2N878NR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nischarin (Homo sapiens (Human)) | BDBM215805 (US9303019, 20) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.80 | -50.8 | n/a | n/a | n/a | n/a | n/a | 7.35 | 37 |
UNIVERSITE DE STRASBOURG US Patent | Assay Description Binding assays were performed at 37° C. using [125I]LNP 911 as radioligand following the general procedure described but adapted to washed whole ... | US Patent US9303019 (2016) BindingDB Entry DOI: 10.7270/Q2N878NR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nischarin (Homo sapiens (Human)) | BDBM215803 (US9303019, 9) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.80 | -50.8 | n/a | n/a | n/a | n/a | n/a | 7.35 | 37 |
UNIVERSITE DE STRASBOURG US Patent | Assay Description Binding assays were performed at 37° C. using [125I]LNP 911 as radioligand following the general procedure described but adapted to washed whole ... | US Patent US9303019 (2016) BindingDB Entry DOI: 10.7270/Q2N878NR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nischarin (Homo sapiens (Human)) | BDBM215800 (US9303019, 1) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 8.10 | -48.0 | n/a | n/a | n/a | n/a | n/a | 7.35 | 37 |
UNIVERSITE DE STRASBOURG US Patent | Assay Description Binding assays were performed at 37° C. using [125I]LNP 911 as radioligand following the general procedure described but adapted to washed whole ... | US Patent US9303019 (2016) BindingDB Entry DOI: 10.7270/Q2N878NR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nischarin (Homo sapiens (Human)) | BDBM215801 (US9303019, 5) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 19 | -45.8 | n/a | n/a | n/a | n/a | n/a | 7.35 | 37 |
UNIVERSITE DE STRASBOURG US Patent | Assay Description Binding assays were performed at 37° C. using [125I]LNP 911 as radioligand following the general procedure described but adapted to washed whole ... | US Patent US9303019 (2016) BindingDB Entry DOI: 10.7270/Q2N878NR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nischarin (Homo sapiens (Human)) | BDBM215804 (US9303019, 13) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 120 | -41.1 | n/a | n/a | n/a | n/a | n/a | 7.35 | 37 |
UNIVERSITE DE STRASBOURG US Patent | Assay Description Binding assays were performed at 37° C. using [125I]LNP 911 as radioligand following the general procedure described but adapted to washed whole ... | US Patent US9303019 (2016) BindingDB Entry DOI: 10.7270/Q2N878NR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-2A/Alpha-2B/Alpha-2C adrenergic receptor (Homo sapiens (Human)) | BDBM215805 (US9303019, 20) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a | 7.5 | n/a |
UNIVERSITE DE STRASBOURG US Patent | Assay Description The membrane preparation was prepared as described by Newman-Tancredi, A.; Nicolas, J,-P.; Audinot, V.; Gavaudan, S.; Verriele, L.; Touzard, M.; Chap... | US Patent US9303019 (2016) BindingDB Entry DOI: 10.7270/Q2N878NR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-2A/Alpha-2B/Alpha-2C adrenergic receptor (Homo sapiens (Human)) | BDBM215800 (US9303019, 1) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a | 7.5 | n/a |
UNIVERSITE DE STRASBOURG US Patent | Assay Description The membrane preparation was prepared as described by Newman-Tancredi, A.; Nicolas, J,-P.; Audinot, V.; Gavaudan, S.; Verriele, L.; Touzard, M.; Chap... | US Patent US9303019 (2016) BindingDB Entry DOI: 10.7270/Q2N878NR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-2A/Alpha-2B/Alpha-2C adrenergic receptor (Homo sapiens (Human)) | BDBM215801 (US9303019, 5) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a | 7.5 | n/a |
UNIVERSITE DE STRASBOURG US Patent | Assay Description The membrane preparation was prepared as described by Newman-Tancredi, A.; Nicolas, J,-P.; Audinot, V.; Gavaudan, S.; Verriele, L.; Touzard, M.; Chap... | US Patent US9303019 (2016) BindingDB Entry DOI: 10.7270/Q2N878NR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-2A/Alpha-2B/Alpha-2C adrenergic receptor (Homo sapiens (Human)) | BDBM215802 (US9303019, 8) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a | 7.5 | n/a |
UNIVERSITE DE STRASBOURG US Patent | Assay Description The membrane preparation was prepared as described by Newman-Tancredi, A.; Nicolas, J,-P.; Audinot, V.; Gavaudan, S.; Verriele, L.; Touzard, M.; Chap... | US Patent US9303019 (2016) BindingDB Entry DOI: 10.7270/Q2N878NR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-2A/Alpha-2B/Alpha-2C adrenergic receptor (Homo sapiens (Human)) | BDBM215803 (US9303019, 9) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a | 7.5 | n/a |
UNIVERSITE DE STRASBOURG US Patent | Assay Description The membrane preparation was prepared as described by Newman-Tancredi, A.; Nicolas, J,-P.; Audinot, V.; Gavaudan, S.; Verriele, L.; Touzard, M.; Chap... | US Patent US9303019 (2016) BindingDB Entry DOI: 10.7270/Q2N878NR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Alpha-2A/Alpha-2B/Alpha-2C adrenergic receptor (Homo sapiens (Human)) | BDBM215804 (US9303019, 13) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a | 7.5 | n/a |
UNIVERSITE DE STRASBOURG US Patent | Assay Description The membrane preparation was prepared as described by Newman-Tancredi, A.; Nicolas, J,-P.; Audinot, V.; Gavaudan, S.; Verriele, L.; Touzard, M.; Chap... | US Patent US9303019 (2016) BindingDB Entry DOI: 10.7270/Q2N878NR | |||||||||||
More data for this Ligand-Target Pair |